Medical Specialties Commons^™

In Vitro Evaluation Of Cancer Patient Immune Responses Following Infusion Of Radiolabeled Murine Monoclonal Antibody, Kelly A. King

Loma Linda University Electronic Theses, Dissertations & Projects

Several monoclonal antibody (MAb) types derived from mice have been developed specifically for the use of targeting human tumors. The specificity of these murine MAb’s for their respective tumor antigens is very high making them potentially good immunotherapeutic agents for cancer treatment and diagnosis. A limiting factor in using these murine MAb’s in patients is the development of human anti-mouse antibody (HAMA). The presence of HAMA may reduce the effectiveness of MAb for tumor targeting. If patient sensitization could be quickly detected following the initial infusion of MAb, then future infusion could be altered or terminated to prevent further sensitization. …

Hypoxanthine-Induced Differentiation Of Cultured Human Leukemia Cells, Gayle Jennette Singleton

Chemistry & Biochemistry Theses & Dissertations

Human cultured leukemia cells appear to have a decreased amount of inosine in their tRNA. When cells with inosine deficient tRNA are placed in a hypoxanthine fortified media, they incorporate hypoxanthine into their tRNA by the action of the enzyme tRNA-hypoxanthine ribosyl transferase. This generates the nucleoside inosine in the tRNA. The cultured human leukemia cell lines, CCRF-CEM, HL-60, and HGPRT(-) HL- 60, incorporate hypoxanthine into their tRNA, as determined by tRNA isolation, hydrolysis, and HPLC analysis. Hypoxanthine treatment dramatically inhibited cell growth in conjunction with partial induction of differentiation in the CCRF-CEM, HL-60, and HGPRT ( - ) HL-60 …

Efficacy Of A Home Made Quality Control Serum, Rukbsana Lalani, Ayesha Molla, Mohammad Khurshid

Section of Haematology/Oncology

With increasing automation in Clinical Laboratories, the requirements for quality control material have greatly increased in order to monitor performance. The constant use of commercial control material is not economically feasible for many countries because of non-availability or the high cost of these materials. Here we describe a simple technique to prepare Home Made Quality Control serum using blood from polycythaemic patients. This preparation is stable for about six months without any alterations in the concentration of any of the chemical constituents. Extensive use of Home Made Quality Control sera in our laboratories have saved about 69% of the amount …

Oncolog, Volume 34, Number 02, April-June 1989, Vicki Huff Phd

OncoLog MD Anderson's Report to Physicians (All issues)

• Bone Marrow Transplantation Supports Patients through High-Dose Chemotherapy
• Genetic Linkage Analysis of Familial Wilms' Tumor
• Osteosarcoma: Expandable Prostheses and Allografts Reduce the Need for Amputation

Oncolog, Volume 34, Number 04, October-December 1989, Gabriel N. Hortobagyi Md

OncoLog MD Anderson's Report to Physicians (All issues)

• For Cancer Patients, Home May Be Their Hospital
• Neoadiuvant Chemotherapy for Patients with Stage III Breast Cancer
• Newer Methods of Delivery To Enhance GI Cancer Treatment

Oncolog, Volume 34, Number 03, July-September 1989, Stephen L. Huber Ms, Nicky Dozier Pharmd, Naguib A. Samaan Md, Phd

OncoLog MD Anderson's Report to Physicians (All issues)

• Understanding Dose Intensity is Essential for Optimizing Chemotherapeutic Regimens
• Dysplastic Nevus Syndrome Identifies Patients at High Risk for Melanoma
• Multiple Endocrine Neoplasia Syndromes

Oncolog, Volume 34, Number 01, January-March 1989, Mark S. Roh Md, Lillian M. Fuller Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Treatment Options for Colorectal Liver Metastases
• Improved Treatments for Non-Hodgkin's Lymphoma
• Early Discharge for Mastectomy Patients Does Not Increase Morbidity